Literature DB >> 34127759

Species variations in tenocytes' response to inflammation require careful selection of animal models for tendon research.

Gil Lola Oreff1, Michele Fenu1, Claus Vogl2, Iris Ribitsch1, Florien Jenner3.   

Abstract

For research on tendon injury, many different animal models are utilized; however, the extent to which these species simulate the clinical condition and disease pathophysiology has not yet been critically evaluated. Considering the importance of inflammation in tendon disease, this study compared the cellular and molecular features of inflammation in tenocytes of humans and four common model species (mouse, rat, sheep, and horse). While mouse and rat tenocytes most closely equalled human tenocytes' low proliferation capacity and the negligible effect of inflammation on proliferation, the wound closure speed of humans was best approximated by rats and horses. The overall gene expression of human tenocytes was most similar to mice under healthy, to horses under transient and to sheep under constant inflammatory conditions. Humans were best matched by mice and horses in their tendon marker and collagen expression, by horses in extracellular matrix remodelling genes, and by rats in inflammatory mediators. As no single animal model perfectly replicates the clinical condition and sufficiently emulates human tenocytes, fit-for-purpose selection of the model species for each specific research question and combination of data from multiple species will be essential to optimize translational predictive validity.

Entities:  

Year:  2021        PMID: 34127759     DOI: 10.1038/s41598-021-91914-9

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  88 in total

1.  Gene expression and matrix turnover in overused and damaged tendons.

Authors:  G P Riley
Journal:  Scand J Med Sci Sports       Date:  2005-08       Impact factor: 4.221

Review 2.  Strategies to optimize the validity of disease models in the drug discovery process.

Authors:  Frank Sams-Dodd
Journal:  Drug Discov Today       Date:  2006-04       Impact factor: 7.851

Review 3.  A review on animal models and treatments for the reconstruction of Achilles and flexor tendons.

Authors:  Marta Bottagisio; Arianna B Lovati
Journal:  J Mater Sci Mater Med       Date:  2017-02-02       Impact factor: 3.896

4.  Phase II and phase III failures: 2013-2015.

Authors:  Richard K Harrison
Journal:  Nat Rev Drug Discov       Date:  2016-11-04       Impact factor: 84.694

Review 5.  The translatability of animal models for clinical development: biomarkers and disease models.

Authors:  Alexandra Wendler; Martin Wehling
Journal:  Curr Opin Pharmacol       Date:  2010-06-09       Impact factor: 5.547

Review 6.  Biologics for tendon repair.

Authors:  Denitsa Docheva; Sebastian A Müller; Martin Majewski; Christopher H Evans
Journal:  Adv Drug Deliv Rev       Date:  2014-11-21       Impact factor: 15.470

Review 7.  The role of animal models in tendon research.

Authors:  M W Hast; A Zuskov; L J Soslowsky
Journal:  Bone Joint Res       Date:  2014-06       Impact factor: 5.853

8.  A Clinical, Biological, and Biomaterials Perspective into Tendon Injuries and Regeneration.

Authors:  Grace Walden; Xin Liao; Simon Donell; Mike J Raxworthy; Graham P Riley; Aram Saeed
Journal:  Tissue Eng Part B Rev       Date:  2016-09-30       Impact factor: 6.389

Review 9.  The role of mouse tumour models in the discovery and development of anticancer drugs.

Authors:  Christopher R Ireson; Mo S Alavijeh; Alan M Palmer; Emily R Fowler; Hazel J Jones
Journal:  Br J Cancer       Date:  2019-06-24       Impact factor: 7.640

Review 10.  Translatability score revisited: differentiation for distinct disease areas.

Authors:  Alexandra Wendler; Martin Wehling
Journal:  J Transl Med       Date:  2017-11-03       Impact factor: 5.531

View more
  7 in total

1.  Defining the Profile: Characterizing Cytokines in Tendon Injury to Improve Clinical Therapy.

Authors:  Ilene Ellis; Lauren V Schnabel; Alix K Berglund
Journal:  J Immunol Regen Med       Date:  2022-03-04

2.  Case Report: Repeated Intralesional Injections of Autologous Mesenchymal Stem Cells Combined With Platelet-Rich Plasma for Superficial Digital Flexor Tendon Healing in a Show Jumping Horse.

Authors:  Luca Melotti; Anna Carolo; Noha Elshazly; Filippo Boesso; Laura Da Dalt; Gianfranco Gabai; Anna Perazzi; Ilaria Iacopetti; Marco Patruno
Journal:  Front Vet Sci       Date:  2022-02-18

3.  Mesenchymal Stem Cell-Derived Extracellular Vesicles in Tendon and Ligament Repair-A Systematic Review of In Vivo Studies.

Authors:  Victor Lu; Maria Tennyson; James Zhang; Wasim Khan
Journal:  Cells       Date:  2021-09-27       Impact factor: 6.600

4.  Galvanic current activates the NLRP3 inflammasome to promote Type I collagen production in tendon.

Authors:  Alejandro Peñin-Franch; José Antonio García-Vidal; Carlos Manuel Martínez; Pilar Escolar-Reina; Rosa M Martínez-Ojeda; Ana I Gómez; Juan M Bueno; Francisco Minaya-Muñoz; Fermín Valera-Garrido; Francesc Medina-Mirapeix; Pablo Pelegrín
Journal:  Elife       Date:  2022-02-24       Impact factor: 8.140

Review 5.  Dynamic Load Model Systems of Tendon Inflammation and Mechanobiology.

Authors:  Lindsay G Benage; James D Sweeney; Morgan B Giers; Ravi Balasubramanian
Journal:  Front Bioeng Biotechnol       Date:  2022-07-15

6.  Interleukin-1β in tendon injury enhances reparative gene and protein expression in mesenchymal stem cells.

Authors:  Drew W Koch; Alix K Berglund; Kristen M Messenger; Jessica M Gilbertie; Ilene M Ellis; Lauren V Schnabel
Journal:  Front Vet Sci       Date:  2022-08-11

7.  TGF-β2 enhances expression of equine bone marrow-derived mesenchymal stem cell paracrine factors with known associations to tendon healing.

Authors:  Drew W Koch; Lauren V Schnabel; Ilene M Ellis; Rowan E Bates; Alix K Berglund
Journal:  Stem Cell Res Ther       Date:  2022-09-16       Impact factor: 8.079

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.